RxDoctor Payments Data

Richard Kyle, MD

Orthopaedic Surgery · Minneapolis, MNNPI 1720186588

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $24,673 of the $25,907 with a category attached, or 95.2%. Encore Medical, LP accounts for 95.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $15,842 and has fallen 98.4% since, to $260 in 2024.

$25,907in general payments, 2019–2025

Across 18 payments — averaging $1439.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$25K
  • Exactech, Inc.$755
  • Stryker$197
  • Smith+Nephew$178
  • Spineology Inc.$88
  • Si-bone, Inc.$15
$38in ownership & investment interests, 2019–2025

Across 10 payments — averaging $3.80 each. An ownership or investment interest held by the physician or an immediate family member.

  • Spineology Inc.$38
  • Activortho, Inc.$0

What the payments were for

  • Royalty or licence$24,67395%
  • Speaking & faculty fees$880%
  • Travel & lodging$5242%
  • Food & beverage$6212%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,907 in reported general payments places this provider in the 80th percentile of 533 orthopaedic surgery providers in Minnesota.

See all orthopaedic surgery providers in Minnesota →

Medicare billing

Part B allowed, 2024
$21,393
Medicare patients
55
Services billed
146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium24$592
Tamsulosin Hcl15$195
Metformin Hcl ErMetformin Hcl12$194
Losartan Potassium13$159
Metoprolol Succinate13$158
Celecoxib13$107
Ibuprofen12$73
Meloxicam17$30
Cephalexin11$18

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Minneapolis

See the full list for Minnesota →

Where these figures come from

Is this you, or does something look wrong? →